August 30, 2021
Tasrif Pharmaceutical Announces Grant of US Patent for Humanized Monoclonal Antibodies Against the Poliovirus Receptor.
August 25, 2021
Tasrif Pharmaceutical Announces Grant of US Patent for Humanized Monoclonal Antibodies Against the Poliovirus Receptor.